Evidence map›Paper›PMID 41876947›Full record

ArticleAnnals of clinical and translational neurology2026

[

Julia S Dorneich, Jonathan A Gernert, Hanna Zimmermann, Lisa Tagnin, Marianthi Zeinaki, Laura Sanzo, Letizia Vogler, Elisabeth Kaufmann, Justina Dargvainiene, Frank Leypoldt and 10 more

Abstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Feasibility of short imaging protocols for [European journal of nuclear medicine and molecular imaging · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Julia S DorneichDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Jonathan A GernertInstitute of Clinical Neuroimmunology, LMU University Hospital, LMU Munich, Munich, Germany.ORCID https://orcid.org/0000-0002-6655-5557
Hanna ZimmermannInstitute for Neuroradiology, LMU University Hospital, LMU Munich, Munich, Germany.
Lisa TagninDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Marianthi ZeinakiDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Laura SanzoDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Letizia VoglerDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Elisabeth KaufmannDepartment of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
Justina DargvainieneInstitute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID https://orcid.org/0009-0002-4114-3748
Frank LeypoldtInstitute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID https://orcid.org/0000-0002-8972-515X
Gérard N BischofLife Molecular Imaging, GmbH, Berlin, Germany.
Robert PerneczkyDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Boris-Stephan RauchmannInstitute for Neuroradiology, LMU University Hospital, LMU Munich, Munich, Germany.ORCID https://orcid.org/0000-0003-4547-6240
Simon LindnerDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Günter U HöglingerDepartment of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
Rudolf A WernerDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Martin KerschensteinerInstitute of Clinical Neuroimmunology, LMU University Hospital, LMU Munich, Munich, Germany.
Tania KümpfelInstitute of Clinical Neuroimmunology, LMU University Hospital, LMU Munich, Munich, Germany.ORCID https://orcid.org/0000-0001-7509-5268
Matthias BrendelDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.ORCID https://orcid.org/0000-0002-9247-2843
Franziska S ThalerInstitute of Clinical Neuroimmunology, LMU University Hospital, LMU Munich, Munich, Germany.ORCID https://orcid.org/0000-0001-6548-0410

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate [

methods[

resultsClinical phenotypes included limbic encephalitis/temporal lobe epilepsy (LE/TLE; n = 17), stiff-person syndrome (n = 4), and cerebellar ataxia (CA; n = 4), with overlap in nine patients. Global [

interpretation[

Indexed as

[18F] fluorodeprenyl‐D2 PET‐CTastrocytosisauto‐antibodiesbiomarkerGAD65‐ab autoimmune encephalitisneuroinflammation

Identifiers

PMID41876947
PMCPMC13394659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.